Literature DB >> 25744227

Immunization of pregnant women against pertussis: the effect of timing on antibody avidity.

Bahaa Abu Raya1, Ellen Bamberger2, Meital Almog3, Regina Peri4, Isaac Srugo5, Aharon Kessel3.   

Abstract

BACKGROUND: The Centers for Disease Control and Prevention recommend tetanus-diphteria-acellular pertussis (Tdap) immunization during pregnancy, preferably at 27-36 weeks gestation. AIMS: First, to assess the relative avidity index (RAI) of umbilical cord immunoglobulin G (IgG) to pertussis toxin (PT) for newborns of women immunized with Tdap during late pregnancy as compared to unimmunized women. Second, to assess whether there is a preferential period of gestational Tdap immunization that provides the highest RAI of umbilical cord IgG to PT.
METHODS: RAI of IgG to PT was assessed via an adapted ELISA using NH4SCN as a dissociating agent.
RESULTS: We found that newborns of women immunized with Tdap during late pregnancy (n=52) had higher mean RAI of umbilical cord IgG to PT than those of unimmunized women (n=8), 73.77%±12.08 (95% CI, 70.41-77.13) vs. 50.23%±21.32 (95% CI, 32.41-68.06), p<0.001. Further, the RAI of umbilical cord IgG to PT was significantly higher in newborns of women immunized at 27-30(+6) weeks gestation (n=20) when compared with newborns of women immunized at 31-36 weeks (n=22) and >36 weeks (n=7), 79.53%±5.61 (95% CI, 76.91-82.16) vs. 71.56%±12.58 (95% CI, 65.98-77.14) vs. 63.93%±17.98 (95% CI, 47.31-80.56), p<0.03.
CONCLUSION: Gestational Tdap immunization between 27 and 30(+6) weeks resulted in the highest avidity of IgG to PT conveyed at delivery as compared with immunization beyond 31 weeks gestation. Future studies should be conducted to confirm our findings to optimize pertussis-controlling strategies.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Immunoglobulin G; Pertussis; Pertussis toxin; Relative avidity index; Tetanus–diphtheria–acellular pertussis maternal immunization

Mesh:

Substances:

Year:  2015        PMID: 25744227     DOI: 10.1016/j.vaccine.2015.02.059

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  One size fits all? Antibody avidity measurement against multiple antigens in maternal vaccination studies.

Authors:  Thomas Rice; Beate Kampmann; Beth Holder
Journal:  Virulence       Date:  2017-04-25       Impact factor: 5.882

2.  The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses : An Individual Participant Meta-analysis.

Authors:  Merryn Voysey; Dominic F Kelly; Thomas R Fanshawe; Manish Sadarangani; Katherine L O'Brien; Rafael Perera; Andrew J Pollard
Journal:  JAMA Pediatr       Date:  2017-07-01       Impact factor: 16.193

3.  Why, when and for what diseases pregnant and new mothers "should" be vaccinated.

Authors:  Giovanni Gabutti; Giorgio Conforti; Alberto Tomasi; Parvanè Kuhdari; Paolo Castiglia; Rosa Prato; Silvia Memmini; Chiara Azzari; Giovanni Vitali Rosati; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

4.  Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.

Authors:  Raïssa Nadège Caboré; Kirsten Maertens; Alexandre Dobly; Elke Leuridan; Pierre Van Damme; Kris Huygen
Journal:  Virulence       Date:  2017-02-22       Impact factor: 5.882

Review 5.  Vaccines in pregnancy: The dual benefit for pregnant women and infants.

Authors:  H Marshall; M McMillan; R M Andrews; K Macartney; K Edwards
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

6.  The Impact of IgG transplacental transfer on early life immunity.

Authors:  Genevieve G Fouda; David R Martinez; Geeta K Swamy; Sallie R Permar
Journal:  Immunohorizons       Date:  2018-01-01

Review 7.  Maternal vaccination for the prevention of influenza: current status and hopes for the future.

Authors:  Varun K Phadke; Saad B Omer
Journal:  Expert Rev Vaccines       Date:  2016-04-22       Impact factor: 5.217

8.  Stage of Gestation at Porcine Epidemic Diarrhea Virus Infection of Pregnant Swine Impacts Maternal Immunity and Lactogenic Immune Protection of Neonatal Suckling Piglets.

Authors:  Stephanie N Langel; Francine C Paim; Moyasar A Alhamo; Alexandra Buckley; Albert Van Geelen; Kelly M Lager; Anastasia N Vlasova; Linda J Saif
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

9.  The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies.

Authors:  Bahaa Abu-Raya; Michelle L Giles; Tobias R Kollmann; Manish Sadarangani
Journal:  Front Immunol       Date:  2019-10-11       Impact factor: 7.561

Review 10.  Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement.

Authors:  Bahaa Abu-Raya; Kirsten Maertens; Kathryn M Edwards; Saad B Omer; Janet A Englund; Katie L Flanagan; Matthew D Snape; Gayatri Amirthalingam; Elke Leuridan; Pierre Van Damme; Vana Papaevangelou; Odile Launay; Ron Dagan; Magda Campins; Anna Franca Cavaliere; Tiziana Frusca; Sofia Guidi; Miguel O'Ryan; Ulrich Heininger; Tina Tan; Ahmed R Alsuwaidi; Marco A Safadi; Luz M Vilca; Nasamon Wanlapakorn; Shabir A Madhi; Michelle L Giles; Roman Prymula; Shamez Ladhani; Federico Martinón-Torres; Litjen Tan; Lessandra Michelin; Giovanni Scambia; Nicola Principi; Susanna Esposito
Journal:  Front Immunol       Date:  2020-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.